Koninklijke Philips Gross Profit 2010-2025 | PHG

Koninklijke Philips annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Koninklijke Philips gross profit for the quarter ending March 31, 2025 was $1.948B, a 3.34% increase year-over-year.
  • Koninklijke Philips gross profit for the twelve months ending March 31, 2025 was $8.435B, a 6.78% increase year-over-year.
  • Koninklijke Philips annual gross profit for 2024 was $8.411B, a 4.34% increase from 2023.
  • Koninklijke Philips annual gross profit for 2023 was $8.061B, a 6.35% increase from 2022.
  • Koninklijke Philips annual gross profit for 2022 was $7.58B, a 10.62% decline from 2021.
Koninklijke Philips Annual Gross Profit
(Millions of US $)
2024 $8,411
2023 $8,061
2022 $7,580
2021 $8,480
2020 $10,031
2019 $9,940
2018 $10,101
2017 $9,246
2016 $11,743
2015 $10,944
2014 $10,908
2013 $12,869
2012 $12,101
2011 $12,044
2010 $12,677
2009 $11,267
Koninklijke Philips Quarterly Gross Profit
(Millions of US $)
2025-03-31 $1,948
2024-09-30 $2,206
2024-06-30 $2,142
2023-06-30 $2,139
2023-03-31 $1,885
2022-06-30 $1,843
2021-06-30 $2,156
2020-06-30 $2,016
2019-06-30 $2,389
2018-06-30 $2,392
2017-06-30 $2,118
2016-12-31 $3,472
2016-09-30 $2,904
2016-06-30 $2,867
2016-03-31 $2,500
2015-12-31 $3,101
2015-09-30 $2,695
2015-06-30 $2,760
2015-03-31 $2,388
2014-12-31 $2,730
2014-09-30 $2,422
2014-06-30 $2,991
2014-03-31 $2,766
2013-12-31 $3,906
2013-09-30 $3,122
2013-06-30 $3,065
2013-03-31 $2,775
2012-12-31 $3,851
2012-09-30 $3,265
2012-06-30 $2,509
2012-03-31 $2,783
2011-12-31 $2,950
2011-09-30 $2,735
2011-06-30 $2,940
2011-03-31 $3,301
2010-12-31 $3,754
2010-09-30 $3,011
2010-06-30 $2,911
2010-03-31 $3,019
2009-12-31 $5,210
2009-09-30 $2,898
2009-06-30 $1,586
2009-03-31 $2,148
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.051B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.407B 27.95
Boston Scientific (BSX) United States $151.037B 37.81
Stryker (SYK) United States $146.527B 30.64
EssilorLuxottica (ESLOY) France $129.703B 0.00
Medtronic (MDT) Ireland $112.146B 15.90
Lonza Group Ag (LZAGY) Switzerland $50.313B 0.00
Haleon (HLN) United Kingdom $49.826B 28.39
ResMed (RMD) United States $36.979B 27.77
Agilent Technologies (A) United States $32.895B 21.44
GE HealthCare Technologies (GEHC) United States $32.794B 15.57
Terumo (TRUMY) Japan $26.561B 34.50
Insulet (PODD) United States $21.941B 86.12
Zimmer Biomet Holdings (ZBH) United States $18.277B 11.74
Baxter (BAX) United States $15.529B 11.59
Smith & Nephew SNATS (SNN) United Kingdom $13.253B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Sunny Optical Technology (SNPTF) China $8.430B 0.00
Bio-Rad Laboratories (BIO) United States $5.971B 20.78
Lantheus Holdings (LNTH) United States $5.642B 14.23
Prestige Consumer Healthcare (PBH) United States $4.203B 18.78
Perrigo (PRGO) Ireland $3.596B 9.11
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.385B 15.42
ICU Medical (ICUI) United States $3.275B 24.15
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $1.997B 13.73
LeMaitre Vascular (LMAT) United States $1.901B 42.49
AtriCure (ATRC) United States $1.730B 0.00
Acuren (TIC) United States $1.271B 0.00
AdaptHealth (AHCO) United States $1.201B 12.19
Neogen (NEOG) United States $1.131B 14.47
BioLife Solutions (BLFS) United States $1.126B 0.00
Green Thumb Industries (GTBIF) United States $1.100B 24.74
Kestra Medical Technologies (KMTS) United States $1.063B 0.00
Phibro Animal Health (PAHC) United States $0.976B 12.48
InMode (INMD) Israel $0.895B 9.02
Capricor Therapeutics (CAPR) United States $0.650B 0.00
Evolus (EOLS) United States $0.647B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Owens & Minor (OMI) United States $0.619B 5.13
Maravai LifeSciences Holdings (MRVI) United States $0.609B 0.00
Curaleaf Holdings (CURLF) Canada $0.584B 0.00
Valneva SE (VALN) France $0.524B 0.00
Surmodics (SRDX) United States $0.420B 0.00
Tilray Brands (TLRY) Canada $0.408B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.76
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.322B 57.20
Canopy Growth (CGC) Canada $0.313B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.289B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Cresco Labs (CRLBF) United States $0.265B 0.00
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 11.87
Sanuwave Health (SNWV) United States $0.239B 0.00
Omeros (OMER) United States $0.221B 0.00
OraSure Technologies (OSUR) United States $0.216B 0.00
Biote (BTMD) United States $0.210B 5.89
Quanterix (QTRX) United States $0.209B 0.00
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Brainsway (BWAY) Israel $0.197B 52.25
High Tide (HITI) Canada $0.193B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.86
Organigram Global (OGI) Canada $0.181B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.134B 0.00
Jin Medical (ZJYL) China $0.120B 0.00
MacroGenics (MGNX) United States $0.112B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.59
Quipt Home Medical (QIPT) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.082B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
Modular Medical (MODD) United States $0.046B 0.00
United-Guardian (UG) United States $0.038B 13.14
Nephros (NEPH) United States $0.036B 48.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Meihua Medical Technologies (MHUA) China $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00